The catalytic (C) subunit of protein kinase A (PKA) is regarded as a framework for the protein kinase family. Its sequence is composed of a conserved core (residues 40 -300) between two segments at the amino and carboxyl termini of the protein. Since the various protein kinases differ in their specificity, it seems reasonable to assume that these nonhomologous segments may be involved in endowing each kinase with its individual specificity. Here we present data to show that the cluster of acidic amino acids ( 328 DDYEEEE
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is now regarded as a prototype for the large family of protein kinases, which share a considerable homology with the sequence of the catalytic (C) subunit of PKA (5, 6) . With the elucidation of the three-dimensional structure of the C subunit by x-ray crystallography (7, 8) , these studies established the basic architectural features of the C subunit, including its unique nucleotide fold, the spatial relationship of the conserved amino acid residues present at its active site (7) (8) (9) (10) (11) , the occurrence of a helix motif (12) that complements the conserved catalytic core (residues 40 -300) (7, 9, 10) , and the scaffolding common to the family of the protein kinases, upon which the individual features of each kinase are built (13) .
Already in the early eighties, it was shown that the C subunit of PKA has a very malleable structure in solution, undergoing distinct conformational changes around physiological pH and ionic strength (14 -16) . Furthermore, these changes were shown to be fully reversible and to be triggered by substrates and inhibitors of the kinase. The first indications of this conformational malleability were obtained by measuring the relative chemical reactivity of the two SH groups of the kinase, located at its core (Cys 199 ) and at its carboxyl-terminal tail (Cys 343 ) (14 -17) . Subsequently, the specific malleability of the carboxyl-terminal tail was illustrated by the intriguing conformation dependence of a specific proteolytic cleavage of this tail by a kinase-splitting membranal proteinase (KSMP), which was found to be quite specific for the kinase (18 -25) . These findings, regarding the functional relevance of the malleability of the C subunit, were supported by studies that monitored the structural consequences of binding inhibitors and substrates on the C subunit, using circular dichroism (26, 27) , differential labeling of carboxyl groups in the carboxyl-terminal tail of the C subunit with a water-soluble carbodiimide (28) , and small angle x-ray scattering (29) of this kinase.
The cleavage of the C subunit by KSMP yields a specific clipped product devoid of kinase activity (18) . This cleavage was found to occur in the native structure of the C subunit, but not in its heat-denatured form (19, 20) , suggesting that KSMP recognizes specifically the three-dimensional structure of the C subunit. The KSMP cleavage site in the native C subunit was recently identified 2 as Glu 332 -Glu
333
, within the cluster of acidic amino acids at the carboxyl-terminal tail (
327

FDDY-EEEEI 335
). This cluster, which accommodates a tyrosine residue (Tyr 330 ) and is located between two hydrophobic amino acids (Phe  327 and Ile   335 ), constitutes the major biorecognition element for KSMP, as indicated by studies with monoclonal antibodies that recognize clusters of Glu and Tyr and the antiidiotypes of these antibodies, and by studies with synthetic peptides based on the sequence around the above-mentioned cluster of acidic amino acids (23) .
Interestingly, a conformation-dependent cleavage by KSMP was shown to occur also in two other kinases that contain a cluster of acidic amino acids at their carboxyl-terminal tails: in the epidermal growth factor receptor kinase and in the insulin receptor kinase (21, 22) . These findings led us to propose that the malleable tail at the carboxyl terminus of each of these kinases may well play "an important role in creating the preferential affinity of these kinases for their in vivo substrates" (22, 23) , i.e. this malleability may have a functional role in their substrate recognition.
X-ray studies have recently shown that in the crystalline state, the C subunit assumes two different conformations referred to as "open" and "closed" (10, 30) . These two conformations represent different relative orientations of the small and large lobes of the C subunit and are associated with the opening and closing of the cleft between the two lobes, which forms the ATP-binding pocket at the active site. This domain movement (31) is accompanied by a movement of the carboxylterminal tail of the C subunit (10), as expected from the abovementioned studies in solution.
Here we show that the conversion of the open conformation of the C subunit to its closed conformation in the ternary complex with its substrates and inhibitory analogs involves an approach of the cluster of acidic amino acids (especially Tyr 330 ) toward a key biorecognition element in the peptide substrates of the C subunit. The importance of this interaction is highlighted by the fact that a single-site mutation of this tyrosine (Y330A) results in a significant increase in the K m of the enzyme for its peptide substrate, Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide); a reduction in its catalytic efficacy as reflected in the V max /K m value for this peptide; and a reduction in the specific activity of the mutant enzyme for a protein substrate (histone type II-A).
MATERIALS AND METHODS
Preparation and Assay of the C Subunit-The C subunit of bovine PKA was purified as described by Reimann and Beham (32) . This purification involves chromatography on DE52, affinity elution of the C subunit by cAMP, and chromatography on hydroxylapatite. To these we added a purification step on a Mono S column (HR 5/5, Pharmacia, Uppsala). The fractions with kinase activity obtained from the hydroxylapatite column were pooled, dialyzed against the equilibration buffer, and applied to the Mono S column pre-equilibrated with 20 mM NaP i buffer (pH 6.8) containing 1 mM EDTA and 1 mM dithiothreitol. The loaded column was washed with the equilibration buffer and then eluted with a linear gradient of 20 -200 mM NaP i (pH 6.8). This column yields two isoforms of the C subunit: C A and C B (33, 34) . The C B isoform was used routinely in this study since it was previously shown that it constitutes a slightly better substrate for KSMP (34) . The enzyme was assayed as described previously (35) with the following modification. The phosphoprotein pellet formed by precipitation with trichloroacetic acid was washed on Whatman GF/C glass filters.
Purification of KSMP-Brush-border membranes obtained from kidneys of 12-week-old Wistar rats were prepared as described by Evers et al. (36) and used in the preparation of KSMP. Starting with 60 rat kidneys (total weight of ϳ80 g), we usually obtained a membrane preparation that contained ϳ130 mg of protein. This preparation was subjected to solubilization (30 min at 4°C) by a solution (100 ml) of 0.8% (w/v) ␤-octyl glucoside and 20 mM Tris-HCl (pH 7.1), ascertaining that the detergent/protein ratio (w/w) was ϳ6:1. The insoluble components were removed by centrifugation at 100,000 ϫ g (30 min at 4°C). The supernatant containing essentially all of the KSMP activity was subjected to purification on a DEAE-Sephacel column (2 ϫ 10 cm) preequilibrated with a buffer (pH 7.1) composed of Tris-HCl (20 mM), MgCl 2 (1.5 mM), NaCl (50 mM), and ␤-octyl glucoside (0.5%, w/v). The concentration of NaCl in the ␤-octyl glucoside extract was adjusted to 50 mM, and the extract was applied to the column. After loading, the column was washed with 10 volumes of the pre-equilibration buffer, and then KSMP was eluted by raising the concentration of NaCl in this buffer to 175 mM. The eluted material was diluted with 20 mM Tris-HCl (pH 7.1) to bring the concentration of ␤-octyl glucoside to 0.3% (w/v). This material was applied to a hydroxylapatite column (1.5 ϫ 4 cm) pre-equilibrated with Tris-HCl (pH 7.1) containing ␤-octyl glucoside (0.3%, w/v). After loading, the column was washed and then eluted with the following series of eluents: 100, 150, 275, and 500 mM NaP i , all at pH 7.1 and containing ␤-octyl glucoside (0.5%, w/v). The protein fraction eluted by the buffer containing 150 mM NaP i was found to possess the highest KSMP specific activity. This fraction was subjected to further purification on a Mono Q column (HR 5/5, Pharmacia) after dialysis against a buffer composed of Tris-HCl (pH 7.1), MgCl 2 (1.5 mM), and ␤-octyl glucoside (0.5%, w/v). Prior to loading the column, the fraction to be subjected to chromatography was dialyzed overnight at 4°C (two buffer changes) against the buffer used for the column pre-equilibration. After loading, the column was washed with 10 volumes of the equilibration buffer and then eluted with a 0 -400 mM NaCl gradient. The fractions that eluted from the column at ϳ200 mM NaCl (which had a maximal KSMP specific activity) were pooled and used.
Assay of KSMP-KSMP was assayed as described previously (18, 19) with the following modifications. The reaction mixture (usually a total volume of 20 l) contained 1 g of the C subunit in a buffer (pH 7.1) composed of Tris-HCl (20 mM), MgCl 2 (1.5 mM), and ␤-octyl glucoside (0.2%, w/v). The reaction was allowed to proceed at 23°C for 2-10 min (depending on the activity of the KSMP preparation used) and arrested by adding the sample buffer used for polyacrylamide gel electrophoresis in the presence of SDS, as described by Laemmli (37) , and then boiling (5 min at 95°C). The gels used usually had a polyacrylamide gradient of 5-20%. The sample buffer used was composed of SDS (1%, w/v), dithiothreitol (40 mM), EDTA (5 mM), and Tris-HCl (20 mM) at pH 6.8. After electrophoresis, the gels were stained with Coomassie Blue (0.25%, w/v) in 50% (v/v) methanol and 7% (v/v) acetic acid, and the extent of cleavage was determined by a computing densitometer with ImageQuant software. Initial rates of cleavage were calculated by determining the formation of the clipped C subunit with time and extrapolation to time 0. A control cleavage of the C subunit was run alongside for reference.
Substrates and Inhibitors of PKA-The ATP analogs and the histone (type II-A) used were purchased from Sigma. Synthetic peptide fragments of the PKA inhibitor known as PKI (residues 6 -22 or 5-24, with a carboxyl terminus in an amide or free carboxyl form) (38) , the phosphorylatable substrate analog of PKI-(5-24) denoted PKS (for structures, see Scheme I), and the PKA peptide substrate known as Kemptide (39) were either purchased from Sigma or synthesized in our laboratory.
Preparation of C Subunit Mutants-The wild-type murine C ␣ subunit gene was cloned into the pRSET-B vector (Invitrogen) as described elsewhere.
3 Site-directed mutations were introduced by oligonucleotidedirected mutagenesis of a uracil-containing single-stranded Kunkel template (40) . The wild-type or mutant enzyme-carrying vector was used for transformation of the Escherichia coli BL21(DE3) strain. The conditions used for growing, induction, and expression were as described elsewhere (41, 42) . Expression was allowed to proceed for 4 h after induction, and then the bacteria were collected by centrifugation and lysed in an ultrasound disintegrator using 20 mM Tris-HCl (pH 7.5) containing 2 mM MgCl 2 , 1 mM dithiothreitol, and 0.1% (w/v) ␤-octyl glucoside. The insoluble particles were removed by centrifugation, the supernatants were then collected, and the level of expression was measured by SDS-polyacrylamide gel electrophoresis. The supernatants were then purified further by chromatography on a Whatman phosphocellulose P-11 column as described elsewhere (43) . The enzyme content was measured by quantitative immunoblotting using an ECL detection system (Amersham International, Buckinghamshire, United Kingdom) for developing. X-ray films were exposed to the ECL-developed blots, and the former were quantitated by computing densitometer scanning. The C subunit purified from bovine heart was routinely included as a standard in these immunoblots. The rabbit primary antibodies used were raised against a peptide ( 6 AKKGSEQESVKEFLAKAK 23 ) whose sequence is identical to that of an amino-terminal segment in the C subunit.
Assay of the Kinase Activity of Expressed C Subunit Mutants-Kemptide was used as a peptide substrate for measuring the kinase activity of expressed C subunit mutants. The assay was performed as described elsewhere (44) . Phosphorylation was carried out at 30°C in a final volume of 50 l containing 20 mM Tris-HCl (pH 7.5), 6 mM MgCl 2 , 1 mM dithiothreitol, a 1-40 ng/ml concentration of the kinase (depending on the specific activity of the tested C subunit mutant), 0.1 Ci of [␥- 32 P]ATP (specific activity of 3000 Ci/mmol) per assay, and varying concentrations of ATP and Kemptide. The reaction was allowed to proceed for 3 min and arrested by a stopping solution containing 100 mM ATP, 100 mM EDTA, and 3% (w/v) SDS in 20 mM Tris-HCl (pH 7.5).
Determination of the Specific Activity of the Wild-type C Subunit and of Its Mutants Using a Protein
Substrate-These specific activities were determined with histone type II-A. The reaction mixtures (200 l) contained a 1-25 ng/ml concentration of the mutant kinase preparation (depending on the specific activity of the tested C subunit mutant), 6 mM MgCl 2 , 1 mg/ml histone, 1 mg/ml bovine serum albumin, 10
32 P]ATP, and 0.1% ␤-octyl glucoside in 20 mM Tris-HCl (pH 7.1). Phosphorylation was allowed to proceed for 3 min at 30°C (securing a linear dependence of the incorporation of phosphate with time and with enzyme concentration) and then arrested by adding 0.5 ml of 10% (w/v) trichloroacetic acid. A 4-ml volume of 1% (w/v) trichloroacetic acid in phosphate-buffered saline was then added, and the mixture was poured on GF/C glass fiber filters placed on a vacuum manifold. The filters were then washed four times with 4 ml of 1% (w/v) trichloroacetic acid in phosphate-buffered saline and transferred to scintillation vials, and their radioactivity was measured in a Packard Tri-Carb scintillation counter. Determinations were performed in triplicates.
Determination of the Kinetic Parameters of the C Subunit Mutants and Comparison with Those of the Wild-type C Subunit-
The kinetic parameters for the phosphotransferase reaction of the C subunit mutants and those of the wild-type C subunit were calculated using the rate equation given by Cleland (45) for bireactant enzyme-catalyzed reactions that follow a sequential pathway (as is the case for PKA) (16, 46 -50) In practice, we measured the activity of the various mutant kinases (as well as the wild-type enzyme) at seven different concentrations of ATP (from 5 to 200 mM), each at seven different concentrations of Kemptide (from 50 to 400 mM). The data obtained were linearized by least-square analysis, and the results were plotted in double-reciprocal plots of 1/v versus 1/A or 1/B. The numerical values of slopes and y axis intercepts were extracted from the equations describing these lines. The intercepts and slopes obtained were replotted versus the reciprocal concentration of ATP and Kemptide, and the kinetic constants (e.g. for substrate B) were calculated from the following equations: slope ϭ
It should be noted that, under the conditions used in these determinations, the phosphate incorporation was linear with time and with enzyme concentration. The values given in Table II were obtained from three experiments, each including all mutants side by side with the wild-type enzyme. , 10)) and the cleavability of the kinase by KSMP, we monitored the cleavage of the C subunit by KSMP under conditions in which the kinase forms binary or ternary complexes with its substrates or inhibitors, i.e. in molecular species equivalent to those prevailing in the various crystalline structures of the C subunit.
Comparison of the X-ray Structures of the Open and Closed Conformations of the C Subunit-This
The closed conformation of the C subunit was established in x-ray studies (8 -10) using the ternary complex of the kinase with ATP and a synthetic peptide derived from the aminoterminal portion of the heat-stable PKA inhibitor (PKI-(5-24)) (Scheme I) (38) . To compare the structural evidence obtained in the crystalline state with the structural evidence obtained in solution, we carried out a systematic study of the effect of ATP and of the synthetic PKI-derived peptide on the KSMP cleavage of the C subunit. As shown in Fig. 1, this cleavage of the C subunit is essentially unaffected by ATP when present in a 4:1 molar ratio and is somewhat slowed down in the presence of a 4:1 molar excess of a synthetic peptide derived from the aminoterminal portion (residues 6 -22) of PKI. However, when these ligands are added together to the C subunit, there is a complete inhibition of the KSMP cleavage (Fig. 1) .
By monitoring the initial rates of cleavage by densitometric scanning of such gels, we obtained a quantitative assessment of the effect of various ligands on the KSMP cleavage of the C subunit. As shown in Fig. 2A , ATP alone affords very little protection from cleavage when added in an excess of up to 10 mol/mol of C subunit. Under the same conditions, the PKI fragment alone affords a considerable protection, although not a complete one. However, full protection from cleavage is achieved under conditions that allow the formation of a ternary complex (i.e. with a combination of the PKI fragment, ATP, and the C subunit in a 1:1:1 molar ratio). This is in agreement with the fact that ATP enhances the affinity of PKA for PKI-(5-24) by ϳ10,000-fold (from ϳ23 M to 2.3 nM) (33, 49) .
The results presented above seem to indicate that open and closed conformations of the C subunit similar to those observed in the crystalline state (9, 10) probably exist also in solution. Furthermore, they indicate that KSMP can distinguish between such structures, cleaving the C subunit in its open (loose) conformation(s), but not in its closed (tight) conformation(s). Interestingly, the binary complex of the C subunit with PKI-(6 -22), which is partially protected from cleavage ( Fig.  2A) , was found to occur in the crystalline state in both a closed and an open conformation (9, 10, 30, 52 ). An explanation for this finding could be that in the presence of the PKI fragment, there is an equilibrium between the open and closed conformations and that this equilibrium is shifted to one or the other direction upon crystallization. However, we cannot exclude the possibility that the iodinated analog favors a different conformation since the two different conformations observed with the binary complex were actually obtained with the PKI fragment itself and with its diiodinated analog, respectively.
In this context, it should be mentioned that when KSMP was originally identified, we observed that the regulatory subunits of PKA (without ATP) protect the C subunit from cleavage by KSMP (18, 19) . This is in agreement with the partial protection afforded by PKI-(6 -22) alone. However, since the regulatory subunits are large proteins, we could not exclude the possibility that the protection from cleavage observed with these subunits is merely due to a steric hindrance, i.e. to a reduced accessibility of the KSMP cleavage site in the C subunit. In addition, it was previously shown that although the substrate/pseudosubstrate sites of the regulatory subunits of PKA and those of the PKI fragment both interact with the C subunit at the catalytic site, the regulatory subunit-binding site is partially distinct from the PKI-binding site (53) .
Effect of ATP Analogs on the Cleavage of the C Subunit by KSMP-
In an attempt to find out whether the closed conformation of the C subunit observed with the PKI fragment and ATP prevails not only with a peptide inhibitor but also with a peptide substrate of the C subunit, we studied the effect of nonhydrolyzable analogs of ATP on the KSMP cleavage, with the aim of identifying an analog that can replace ATP in a ternary complex, without allowing a phospho-transfer reaction to take place in the course of the experiment.
As shown in Fig. 3 , when the effect of ATP is monitored over a wide range of nucleotide/C subunit molar ratios, protection of the C subunit from cleavage can be achieved. However, this occurs at an excess of 200 -300 mol of ATP/mol of kinase, i.e. at an ATP concentration of 200 -300 M, well above its K d . Under these conditions, GTP does not afford significant protection, even if its excess is raised to 1000 mol/mol of C subunit (Fig. 3) . A few other nonhydrolyzable analogs of ATP, such as ATP␥S, App(NH)p, and App(CH 2 )p, or ADP (which has no ␥-phosphate) afford some protection from cleavage, although a larger excess of the analog is required for achieving complete protection of the C subunit from cleavage (Fig. 3) . This raises the possibility that the closed conformation of the C subunit might be formed in solution with ATP alone. However, at high concentrations of nucleotides, the inhibition of the KSMP cleavage may, at least in part, be due not to its effect on the C subunit, but to an inhibition of the proteinase itself. This is due to the fact that KSMP is a metalloenzyme (20) , and such nucleotides can bind the metal ions essential for its activity. In spite of this, the effect of ATP analogs can be evaluated at low concentrations by measuring their contribution in conjunction with a peptide substrate or inhibitor of the C subunit. For example, when either ADP or App(NH)p is added to the C subunit in addition to PKI- (6 -22) , it enhances the protection of the C subunit from KSMP cleavage at an essentially stoichiometric molar ratio of C subunit/PKI fragment/ATP analog (Fig. 2B) , i.e. at a low nucleotide concentration. able analog of ATP (ternary complex). It was found that PKS by itself affords significant protection from cleavage and that it provides almost complete protection in the presence of App(NH)p at essentially stoichiometric ratios with the C subunit (Fig. 4A) , which is similar to the PKI inhibition ( Fig. 2A) . This result indicates that not only an inhibitor, but also a high affinity phosphorylatable substrate of the C subunit provides the kinase with considerable protection from cleavage. It should be noted, however, that the commonly used peptide substrate of PKA, Kemptide (39) (Scheme I), which does not contain some of the affinity-contributing side chains in the PKI fragment (Phe 10 , which interacts with subsite p-11, and Arg 15 , which interacts with subsite p-6 (3, 8, 54, 55) ), is not an inhibitor of the KSMP cleavage, even when added in a molar excess of 400 mol of peptide/mol of C subunit (Fig. 4B) . Furthermore, even when ADP is added together with Kemptide, this peptide substrate does not protect the C subunit from cleavage: the partial protection observed (Fig. 4B, å) can be fully accounted for by ADP alone (Fig. 4B, Ç) . The failure of Kemptide (in contrast to PKS) to provide protection to the C subunit from KSMP cleavage could be associated with the significantly higher affinity of the C subunit for PKS (3, 50, 54) .
The Ternary Complex of the C Subunit with PKS (a Substrate Analog of PKI) Is Also in the Noncleavable
The Malleability of the Carboxyl-terminal Tail of the C Subunit Involves a Distinct Movement of Its Cluster of Acidic Amino
Acids-On the basis of a few crystal structures of the C subunit that assume open or closed conformations (8, 10, 30) , it was recently concluded (10) that the apoenzyme of the kinase (no substrate or inhibitor bound) assumes an open conformation, the binary complex of PKA with PKI-(5-24) alone can assume an open or a closed conformation, while a ternary complex with both ATP and PKI assumes a closed conformation (8 -11) . Small angle x-ray scattering and Fourier transform infrared spectroscopy studies of the C subunit in solution have shown that this kinase contracts upon complex formation with the inhibitor peptide PKI-(5-22)-amide or with this peptide and ATP (29) .
The conformational change involved in the conversion of an open to a closed conformation of the C subunit was described as a "rotation of the small lobe of the enzyme and a displacement of the carboxyl-terminal 30 residues" (10) . As shown in Fig. 5 , these two conformations distinctly differ in the location of the cluster of acidic amino acids (   327   FDDYEEEEI   335 ; highlighted in yellow), which moves closer to the peptide inhibitor. This movement is quite pronounced for Tyr 330 , whose phenolic hydroxyl approaches the nitrogen atoms of the Arg 18 side chain (yellow) stemming from the backbone of the peptide inhibitor (red). The movement of Tyr 330 of PKA toward the Arg 18 side chain of the inhibitor is noteworthy since this arginine residue is located in a position equivalent to subsite p-3 in PKA substrates and since this subsite constitutes an important specificity element in the consensus sequence of physiological PKA substrates (3, 39, 54 -60) . This movement of Tyr 330 supports our suggestion that the cluster of acidic amino acids at the tail of PKA is involved "in creating the preferential affinity of the kinase for its in vivo substrates" (22, 23) . Table I Table I ) moves ϳ7 Å closer to the charged nitrogen atoms of Arg 18 , to reach a distance of ϳ3 Å (Table I) .
In an attempt to assess the involvement of Tyr 330 in the substrate recognition process, we prepared three single-site mutations of the Tyr residue at position 330 and measured the effect of each of these mutations on the K m and V max of the kinase. As shown in Table II, replacing Tyr  330 by Ala results in an ϳ6-fold increase in K m for ATP and almost a 30-fold increase in the K m for the peptide substrate Kemptide. In parallel, there is a 40-fold decrease in V max . Therefore, this single-site mutation of Tyr 330 causes a very significant disruption of the catalytic efficacy of the kinase, as evident from an ϳ1100-fold reduction in the V max /K m ratio for Kemptide (Table II) .
A major factor in this disruption is the reduction in the affinity of the kinase for its peptide substrate, raising the possibility that Tyr 330 , and especially the phenolic ring absent in the Y330A mutant, may contribute directly to the substrate recognition of the kinase. To further analyze this contribution, we prepared two other mutants: a Y330F mutant, which does not possess the phenolic hydroxyl yet still has the phenyl ring, and a Y330S mutant, which lacks the phenyl ring yet still has a hydroxyl group (even though it is at a shorter distance from the peptide backbone). The results depicted in Table II indicate that both the phenyl ring and the phenolic hydroxyl contribute to the K m of the kinase for its peptide substrate: the phenyl ring presumably contributes to maintaining the preferred conformation for peptide and ATP binding by providing packing or van der Waals interactions with residues in the conserved core, and the phenolic hydroxyl contributes to an interaction with the basic amino acid at position p-3, i.e. to the substrate recognition of the enzyme. It should be emphasized that this interaction (possibly a hydrogen bond) is only one out of several interactions involved in the recognition of the consensus sequence by PKA. This is evident from the fact that both the Y330F and Y330A mutants are still active enzymes (although catalytically less efficient).
In search of additional evidence illustrating the importance of the phenyl ring and the phenolic hydroxyl of Tyr 330 in the catalytic function of the kinase, we tested each of the abovementioned Tyr 330 mutants on a protein substrate of the C subunit. As shown in Table III, the replacement of Tyr  330 by either Ala or Ser significantly lowers the specific activity of the enzyme even on a protein substrate. A more limited yet still significant effect was observed with the Y330F mutant. The difference in the relative effect of the various mutations on the catalytic function of the enzyme is not clear. However, it might be associated with the fact that the binding of protein substrates to the C subunit most likely involves multiple interactions, and consequently, a smaller relative contribution is left to each atom in an individual side chain. In fact, this may be the reason behind the observation that PKA, which optimally acts on peptide substrates containing an RRXS/T sequence (39, 58, 60) , also acts on protein substrates containing an XRXS/T sequence, lacking an Arg residue at position p-3 (59) .
Concluding Remarks-The results presented above, taken together with earlier data in the literature, make it reasonable to conclude that the structural malleability of the carboxylterminal "tail" of the C subunit and specifically the mobility of its cluster of acidic amino acids ( 328 DDYEEEE
334
) may have a functional role in creating the specific affinity of the kinase for its physiological substrates. This is based on the following observations. (a) The structural malleability of the C subunit occurs under physiological conditions, i.e. in solution, at neutral pH, and at physiological values of ionic strength. The show a significant contribution of Tyr 330 to the affinity of PKA for its substrates/inhibitors and to its catalytic efficacy (this paper). The carboxyl-terminal tail of the C subunit and presumably of other protein kinases may therefore constitute an important biorecognition element for the purpose of specific catalysis and regulation. 
